Bio-Techne (TECH) Net Margin (2009 - 2026)

Bio-Techne (TECH) recorded quarterly Net Margin of 16.39% in Q1 2026, up 27.6% quarter-over-quarter from 12.85% in Q4 2025, and up 925.0% on a YoY basis from 1.6% in Q1 2025.

Bio-Techne (TECH) Net Margin (2009 - 2026) Analysis & Trends

Bio-Techne's Net Margin history runs 18 years deep, the most recent figure standing at 16.39% for Q1 2026.

  • In Q1 2026, Net Margin rose 925.0% year-over-year to 16.39%; the TTM figure through Mar 2026 stood at 1.88% (down 479.0% YoY), while the FY2025 annual figure was 1.1%, down 1120.0% from the prior year.
  • Net Margin was 16.39% for Q1 2026 at Bio-Techne, up from 12.85% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 4486.7% in Q3 2022 to a low of 32.97% in Q2 2025.
  • Historically, Net Margin has averaged 274.57% across 5 years, with a median of 15.16% in 2023.
  • The sharpest annual moves came in 2022 and 2023: Net Margin soared 445993 bps in 2022, then plunged 446829 bps in 2023.
  • A 5-year view of Net Margin shows it stood at 18.41% in 2022, then sank by 45 bps to 10.08% in 2023, then increased by 17 bps to 11.75% in 2024, then gained by 9 bps to 12.85% in 2025, then advanced by 28 bps to 16.39% in 2026.
  • The last three Net Margin figures came in at 16.39% (Q1 2026), 12.85% (Q4 2025), and 13.33% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Bio-Techne 9.04 Bn 8.83 Bn 208.29 Mn 16.39%

Historic Data

Download Data
DateValue
Mar 31, 2026 16.39%
Dec 31, 2025 12.85%
Sep 30, 2025 13.33%
Jun 30, 2025 -32.97%
Mar 31, 2025 7.14%
Dec 31, 2024 11.75%
Sep 30, 2024 11.61%
Jun 30, 2024 -3.42%
Mar 31, 2024 16.17%
Dec 31, 2023 10.08%
Sep 30, 2023 18.41%
Jun 30, 2023 15.16%
Mar 31, 2023 23.87%
Dec 31, 2022 18.41%
Sep 30, 2022 4,486.70%
Jun 30, 2022 21.48%
Mar 31, 2022 20.71%
Dec 31, 2021 26.76%
Sep 30, 2021 26.77%
Jun 30, 2021 -25.43%